These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32114455)
1. G82S RAGE polymorphism is associated with Alzheimer's disease. Chellappa RC; Rani P Front Biosci (Elite Ed); 2020 Mar; 12(1):150-161. PubMed ID: 32114455 [TBL] [Abstract][Full Text] [Related]
2. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population. Ataç ZS; Alaylıoğlu M; Dursun E; Gezen-Ak D; Yılmazer S; Gürvit H J Clin Neurosci; 2019 Jan; 59():197-201. PubMed ID: 30389362 [TBL] [Abstract][Full Text] [Related]
3. Association between the RAGE G82S polymorphism and Alzheimer's disease. Li K; Dai D; Zhao B; Yao L; Yao S; Wang B; Yang Z J Neural Transm (Vienna); 2010 Jan; 117(1):97-104. PubMed ID: 19902324 [TBL] [Abstract][Full Text] [Related]
4. G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology. C RC; Lukose B; Rani P PLoS One; 2020; 15(10):e0225487. PubMed ID: 33119615 [TBL] [Abstract][Full Text] [Related]
5. Association of the RAGE G82S polymorphism with Alzheimer's disease. Daborg J; von Otter M; Sjölander A; Nilsson S; Minthon L; Gustafson DR; Skoog I; Blennow K; Zetterberg H J Neural Transm (Vienna); 2010 Jul; 117(7):861-7. PubMed ID: 20567859 [TBL] [Abstract][Full Text] [Related]
6. Association Between the G82S Polymorphism of the Receptor Gene for Advanced Glycation End-products and Soluble Serum Levels RAGE with Diabetic Nephropathy in the White (Asian) Race. Rezaei Arnesa A; Hajian S; Salemi Bazargani S; Salahshourifar I; Moghbelinejad S; Abdolvahabi Z; Yaghoobzadeh H; Fathi M; Piri H Iran J Kidney Dis; 2024 May; 18(3):179-186. PubMed ID: 38904338 [TBL] [Abstract][Full Text] [Related]
7. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model. Son M; Oh S; Park H; Ahn H; Choi J; Kim H; Lee HS; Lee S; Park HJ; Kim SU; Lee B; Byun K Brain Behav Immun; 2017 Nov; 66():347-358. PubMed ID: 28760504 [TBL] [Abstract][Full Text] [Related]
8. Relationship Between Peripheral Transport Proteins and Plasma Amyloid-β in Patients with Alzheimer's Disease Were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis. Gao L; Wang J; Jiang Y; Wei S; Shang S; Chen C; Dang L; Huo K; Deng M; Wang J; Qu Q J Alzheimers Dis; 2020; 78(2):699-709. PubMed ID: 33016902 [TBL] [Abstract][Full Text] [Related]
9. APOE ε4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism. Deo P; Dhillon VS; Chua A; Thomas P; Fenech M J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(10):1899-1905. PubMed ID: 31677348 [TBL] [Abstract][Full Text] [Related]
10. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333 [TBL] [Abstract][Full Text] [Related]
11. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease. Prasad K Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281 [TBL] [Abstract][Full Text] [Related]
12. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease. Webster SJ; Mruthinti S; Hill WD; Buccafusco JJ; Terry AV Neuromolecular Med; 2012 Jun; 14(2):119-30. PubMed ID: 22415896 [TBL] [Abstract][Full Text] [Related]
13. Decreased soluble RAGE in neutrophilic asthma is correlated with disease severity and RAGE G82S variants. Lyu Y; Zhao H; Ye Y; Liu L; Zhu S; Xia Y; Zou F; Cai S Mol Med Rep; 2018 Mar; 17(3):4131-4137. PubMed ID: 29257350 [TBL] [Abstract][Full Text] [Related]
14. Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism. Deo P; Dhillon VS; Thomas P; Fenech M Cells; 2023 Jun; 12(12):. PubMed ID: 37371132 [TBL] [Abstract][Full Text] [Related]
15. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease. Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598 [TBL] [Abstract][Full Text] [Related]
16. Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease. Zhang L; Postina R; Wang Y Cell Mol Life Sci; 2009 Dec; 66(24):3923-35. PubMed ID: 19672558 [TBL] [Abstract][Full Text] [Related]
17. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. Fang F; Lue LF; Yan S; Xu H; Luddy JS; Chen D; Walker DG; Stern DM; Yan S; Schmidt AM; Chen JX; Yan SS FASEB J; 2010 Apr; 24(4):1043-55. PubMed ID: 19906677 [TBL] [Abstract][Full Text] [Related]
18. Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case-control study. Takeshita Y; Shibata N; Kasanuki K; Nagata T; Shinagawa S; Kobayashi N; Ohnuma T; Suzuki A; Kawai E; Takayama T; Nishioka K; Motoi Y; Hattori N; Nakayama K; Yamada H; Arai H Int J Geriatr Psychiatry; 2017 Dec; 32(12):1241-1246. PubMed ID: 27699858 [TBL] [Abstract][Full Text] [Related]
19. Autoimmunity in Alzheimer's disease as evidenced by plasma immunoreactivity against RAGE and Abeta42: complication of diabetes. Mruthinti S; Schade RF; Harrell DU; Gulati NK; Swamy-Mruthinti S; Lee GP; Buccafusco JJ Curr Alzheimer Res; 2006 Jul; 3(3):229-35. PubMed ID: 16842100 [TBL] [Abstract][Full Text] [Related]
20. Blood Triglyceride and High-Density Lipoprotein Levels Are Associated with Plasma Amyloid-β Transport: A Population-Based Cross-Sectional Study. Wei S; Shang S; Dang L; Gao F; Gao Y; Gao L; Chen C; Huo K; Wang J; Wang J; Qu Q J Alzheimers Dis; 2021; 84(1):303-314. PubMed ID: 34542070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]